1. Home
  2. BLX vs EVO Comparison

BLX vs EVO Comparison

Compare BLX & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLX
  • EVO
  • Stock Information
  • Founded
  • BLX 1977
  • EVO 1993
  • Country
  • BLX Panama
  • EVO Germany
  • Employees
  • BLX N/A
  • EVO N/A
  • Industry
  • BLX Commercial Banks
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • BLX Finance
  • EVO Health Care
  • Exchange
  • BLX Nasdaq
  • EVO Nasdaq
  • Market Cap
  • BLX 1.4B
  • EVO 1.4B
  • IPO Year
  • BLX N/A
  • EVO 2021
  • Fundamental
  • Price
  • BLX $41.17
  • EVO $4.05
  • Analyst Decision
  • BLX
  • EVO Buy
  • Analyst Count
  • BLX 0
  • EVO 2
  • Target Price
  • BLX N/A
  • EVO $5.90
  • AVG Volume (30 Days)
  • BLX 103.5K
  • EVO 161.2K
  • Earning Date
  • BLX 07-22-2025
  • EVO 05-06-2025
  • Dividend Yield
  • BLX 6.10%
  • EVO N/A
  • EPS Growth
  • BLX 13.55
  • EVO N/A
  • EPS
  • BLX 5.60
  • EVO N/A
  • Revenue
  • BLX $289,499,000.00
  • EVO $851,944,444.00
  • Revenue This Year
  • BLX $13.23
  • EVO $10.08
  • Revenue Next Year
  • BLX $7.79
  • EVO $10.99
  • P/E Ratio
  • BLX $7.30
  • EVO N/A
  • Revenue Growth
  • BLX 13.37
  • EVO 1.50
  • 52 Week Low
  • BLX $27.37
  • EVO $2.84
  • 52 Week High
  • BLX $42.88
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • BLX 57.69
  • EVO 50.68
  • Support Level
  • BLX $40.45
  • EVO $3.99
  • Resistance Level
  • BLX $41.90
  • EVO $4.15
  • Average True Range (ATR)
  • BLX 0.70
  • EVO 0.13
  • MACD
  • BLX -0.08
  • EVO -0.02
  • Stochastic Oscillator
  • BLX 71.48
  • EVO 26.47

About BLX Banco Latinoamericano de Comercio Exterior S.A.

Banco Latinoamericano de Comercio Exterior SA provides financial solutions to financial institutions, companies, and investors doing business in Latin America, supporting trade and regional integration. The Bank provides foreign trade solutions to a select client base of American financial institutions and corporations and has developed a network of correspondent banking institutions with access to the international capital markets. It has two business segments: the Commercial Business Segment and the Treasury Business Segment. The majority of its revenue is generated from the Commercial Business segment.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: